Cannabidiol efficacy and clobazam status: A systematic review and meta‐analysis

Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety

(2020) Simona Lattanzi et al.   CNS DRUGS

Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome

(2020) Ian Miller et al.   JAMA Neurology

The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights

(2020) Willian Lazarini-Lopes et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety

(2019) Simona Lattanzi et al.   DRUGS

Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam

(2019) Michael A. Rogawski   EPILEPSY & BEHAVIOR

Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program

(2019) Tyler E. Gaston et al.   EPILEPSY & BEHAVIOR

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions

(2019) Lyndsey L. Anderson et al.   EPILEPSIA

Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop‐seizure frequency

(2019) Kirsten Riber Bergmann et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam

(2019) Taylor E. Savage et al.   EPILEPSY RESEARCH

Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis

(2018) Simona Lattanzi et al.   CEREBROVASCULAR DISEASES

Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis

(2018) Simona Lattanzi et al.   CNS DRUGS

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

(2018) Elizabeth A Thiele et al.   LANCET

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

(2018) Orrin Devinsky et al.   NEUROLOGY

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

(2018) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis

(2018) Simona Lattanzi et al.   CNS DRUGS

Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis

(2018) Simona Lattanzi et al.   DRUGS

Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis

(2017) Simona Lattanzi et al.   JOURNAL OF NEUROLOGY

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

(2017) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex

(2016) Evan J. Hess et al.   EPILEPSIA

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

(2016) Orrin Devinsky et al.   LANCET NEUROLOGY

Brivaracetam add-on for refractory focal epilepsy

(2016) Simona Lattanzi et al.   NEUROLOGY

Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy

(2015) Alexandra L. Geffrey et al.   EPILEPSIA

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE